BDgene Therapeutics
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A gene therapy biotech using exosome delivery to treat infectious diseases and cancer.
Infectious DiseaseOncologyGene Therapy
Technology Platform
Proprietary exosome-based non-viral delivery platform for targeted gene therapy.
Opportunities
Potential to revolutionize treatment for persistent viral infections with a one-time curative therapy.
Risk Factors
High clinical and regulatory risk associated with first-in-human gene therapies and novel delivery platforms.
Competitive Landscape
Competes with viral vector gene therapy companies and other biotechs targeting HIV and solid tumors.